VCI Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
VCM
VPM
EIG
VCI Wealth Management's DGX Position: Q1 2026 in Review
VCI Wealth Management reduced its Quest Diagnostics (DGX) stake by 8.1% in Q1 2026, selling an estimated $148K and leaving 8,662 shares worth $1.7M. The position accounts for 0.47% of the portfolio, ranked #44.
VCI Wealth Management first reported a position in DGX in Q4 2025 and has held it in 2 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- VCI Wealth Management held 8,662 shares of Quest Diagnostics worth $1.7M as of Q1 2026.
- VCI Wealth Management sold 761 Quest Diagnostics shares in Q1 2026, an estimated $148K.
- Quest Diagnostics made up 0.47% of VCI Wealth Management's portfolio in Q1 2026, its #44 holding.
- VCI Wealth Management first reported a position in Quest Diagnostics in Q4 2025 and has held it in 2 quarters since.
- 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on VCI Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.